|
This instrument amends the Therapeutic Goods Advertising Code (No.2) 2018 to replace references to the Therapeutic Goods (Restricted Representations—COVID-19 Vaccines) Permission (No. 2) 2021 with references to the Therapeutic Goods (Restricted Representations—COVID-19 Vaccines) Permission (No. 3) 2021.
|